Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Ostrosky-Zeichner

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Expert Opinion on Investigational Drugs|June 4, 2004
Novel approaches to antifungal prophylaxisLuis Ostrosky-Zeichner
The American Journal of Medicine|December 27, 2011
Invasive mycoses: diagnostic challengesLuis Ostrosky-Zeichner
Critical Care Medicine|December 16, 2004
Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?Luis Ostrosky-Zeichner
Critical Care Medicine|February 21, 2012
Systemic antifungal therapy in patients without documented invasive fungal infection: a peek into the world of empirical antifungal therapy*Luis Ostrosky-Zeichner
Current Opinion in Infectious Diseases|September 4, 2009
Issues in the design and interpretation of antifungal drug trials in the critically illLuis Ostrosky-Zeichner
The Journal of Antimicrobial Chemotherapy|November 19, 2016
40 years of medical mycology at JACLuis Ostrosky-Zeichner
Critical Care Medicine|April 20, 2004
Medical order formatting in the era of patient safetyLuis Ostrosky-Zeichner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2023
Coronavirus Disease 2019: ShehecheyanuLuis Ostrosky-Zeichner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2021
Candidemia: An Infection Prevention Issue?Luis Ostrosky-Zeichner
Critical Care Medicine|September 9, 2005
Prophylaxis for invasive candidiasis in the intensive care unit: is it time?Luis Ostrosky-Zeichner
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Expert Opinion on Investigational Drugs|June 4, 2004
Novel approaches to antifungal prophylaxisLuis Ostrosky-Zeichner
The American Journal of Medicine|December 27, 2011
Invasive mycoses: diagnostic challengesLuis Ostrosky-Zeichner
Critical Care Medicine|December 16, 2004
Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?Luis Ostrosky-Zeichner
Critical Care Medicine|February 21, 2012
Systemic antifungal therapy in patients without documented invasive fungal infection: a peek into the world of empirical antifungal therapy*Luis Ostrosky-Zeichner
Current Opinion in Infectious Diseases|September 4, 2009
Issues in the design and interpretation of antifungal drug trials in the critically illLuis Ostrosky-Zeichner
The Journal of Antimicrobial Chemotherapy|November 19, 2016
40 years of medical mycology at JACLuis Ostrosky-Zeichner
Critical Care Medicine|April 20, 2004
Medical order formatting in the era of patient safetyLuis Ostrosky-Zeichner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2023
Coronavirus Disease 2019: ShehecheyanuLuis Ostrosky-Zeichner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2021
Candidemia: An Infection Prevention Issue?Luis Ostrosky-Zeichner
Critical Care Medicine|September 9, 2005
Prophylaxis for invasive candidiasis in the intensive care unit: is it time?Luis Ostrosky-Zeichner
Pageof 21